Katheleen Gardiner, PhD

Dr. Katheleen Gardiner is a Professor in the Department of Pediatrics at the University of Colorado Denver and the Linda Crnic Institute for Down Syndrome. Dr. Gardiner received a B.S. degree in Honors Physics from McGill University in Montreal. She then spent 2 ½ years teaching high school general science and physics in Kanye, Botswana. She received a PhD from the Department of Biophysics and Genetics at the University of Colorado Health Sciences Center, for studies on RNA processing in bacteria, work which subsequently was awarded a Nobel Prize.

During a postdoctoral fellowship at the Eleanor Roosevelt Institute in Denver, Dr. Gardiner began working on Down syndrome, initially mapping genes on human chromosome 21 at the start of the human genome project. This work led to her chairing an international committee on genomic sequence annotation when the complete DNA sequence of human chromosome 21 was generated and published in 2000. Dr. Gardiner has continued to focus her research on human chromosome 21 and Down syndrome at the Eleanor Roosevelt Institute, then at the University of Denver. She moved to the University of Colorado in 2007 and joined the Crnic Institute for Down Syndrome in 2012. Current research focuses on protein expression in mouse and human model systems of Down syndrome, and combines wet bench experimental work with computational approaches. The goal is to identify critical patterns in gene expression that underlie learning and memory deficits and to manipulate these with drug treatments to rescue cognitive deficits.

Dr. Gardiner has organized that last two international conferences on Down syndrome and the biology of human chromosome 21 (in 2007 and 2004) in Washington DC, and co-organized similar conferences in 2000 and 1997, held at the Jackson Laboratory in Bar Harbor, and the Max Planck Institute in Berlin, respectively. She recently organized a conference entitled “Cognition in Down syndrome: molecular, cellular and behavioral phenotypes and the promise of pharmacotherapeutics.” It was held in Washington, DC, April 13-15, 2013.

• About the Linda Crnic Institute for Down Syndrome
• In Memory of Dr. Linda Crnic
• Linda Crnic Institute for Down Syndrome Key Scientists
  • Huntington Potter, PhD
    • Alzheimer’s & Down syndrome research by Huntington Potter, PhD
  • Katheleen Gardiner, PhD
  • Tom Blumenthal, PhD
• Linda Crnic Institute for Down Syndrome Staff Members
• Linda Crnic Institute for Down Syndrome: Mission, Vision and Values
• Scientific Advisory Board of the Linda Crnic Institute
  • Jeanne Lawrence, PhD
  • Kristi Anseth, PhD
  • Leslie Leinwand, PhD
  • Roger Reeves, PhD
  • Stylianos Antonarakis, MD
  • Thomas R. Cech, PhD